Dr. Lisa Burry
Dr. Lisa Burry is a Clinician Scientist and Clinical Pharmacy
Specialist at Mount Sinai Hospital and an Assistant Professor in the
Leslie Dan Faculty of Pharmacy, University of Toronto.
Dr. Burry has extensive expertise in patient and drug safety in
emergency, trauma and critical care environments. Her research
interests focus on delirium, sedation, analgesia, and chemical and
physical restraint in the critical care unit. She is a member of the
Canadian Critical Care Trials Group and served on the steering
committee of the SLEAP trial assessing daily sedation interruption on
duration of mechanical ventilation and ICU stay.
In 2015 Dr. Burry was named a Fellow of the international Society of
Critical Care Medicine, one of only 2 Canadians to receive the
designation that year. Previously she received the Baxter Award for
Excellence (as co-recipient) from the Canadian Association of Critical
Care Nurses and her work ranked within the top 3 of over 1400 abstracts
presented at the European Society of Critical Care Medicine (as
co-recipient) meeting in 2012.
Dr. Burry is a member of the editorial board for the journal
Intensive Care Medicine, and she chairs the Emergency & Trauma
Medicine Editorial Board for the journal Annals of Pharmacotherapy.
She is also a member of the Patient Safety Group of the Society of
Critical Care Medicine and a member of the disaster management
committees with American College of Chest Physicians and the Society of
Critical Care Medicine.
Dr. Burry obtained her PharmD degree from the University of Toronto
and has published more than 60 primary research publications in